Bramlage, Peter
Lanzinger, Stefanie
Mühldorfer, Steffen
Milek, Karsten
Gillessen, Anton
Veith, Roman
Ohde, Tobias
Danne, Thomas
Holl, Reinhard W.
Seufert, Jochen
Funding for this research was provided by:
Abbott
AstraZeneca
Bayer Vital
Boehringer Ingelheim
Sanofi
German Diabetes Society
German Centre for Diabetes Research (82DZD14E03)
Article History
Received: 9 March 2023
Accepted: 25 April 2023
First Online: 8 May 2023
Declarations
:
: The DPV initiative, which was established in 1995, was approved by the ethics committee of the University of Ulm, and data collection was approved by local review boards. The DIVE registry was established in Germany in 2011. The protocol was approved by the ethics committee of the Medical School of Hannover, and all patients included in the DIVE registry provided written informed consent.
: Not applicable.
: JS and TD report Grants and personal fees from Abbott, AstraZeneca, and Sanofi, outside the submitted work. PB reports to have received research support from the funders of DIVE. SL, SM, KM, AG, RV, TO and RWH have no competing interests to disclose.